相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mitochondria in cancer: clean windmills or stressed tinkerers?
Dario C. Altieri
TRENDS IN CELL BIOLOGY (2023)
Saikosaponin A enhances Docetaxel efficacy by selectively inducing death of dormant prostate cancer cells through excessive autophagy
Jiling Feng et al.
CANCER LETTERS (2023)
Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix-mediated tumor cell adaptation and tolerance to BRAF-targeted therapy in melanoma
Ilona Berestjuk et al.
EMBO MOLECULAR MEDICINE (2022)
Therapeutic targeting of undruggable MYC
Victor Llombart et al.
EBIOMEDICINE (2022)
Advancements, Challenges, and Future Directions in Tackling Glioblastoma Resistance to Small Kinase Inhibitors
Federica Fabro et al.
CANCERS (2022)
Slow-cycling (dormant) cancer cells in therapy resistance, cancer relapse and metastasis
Sukanya Basu et al.
SEMINARS IN CANCER BIOLOGY (2022)
Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche
Pilar Baldominos et al.
CELL (2022)
Cooperative interaction between ERα and the EMT-inducer ZEB1 reprograms breast cancer cells for bone metastasis
Nastaran Mohammadi Ghahhari et al.
NATURE COMMUNICATIONS (2022)
Tumor Dormancy: Biologic and Therapeutic Implications
Vanshika Balayan et al.
WORLD JOURNAL OF ONCOLOGY (2022)
YES1: A Novel Therapeutic Target and Biomarker in Cancer
Irati Garmendia et al.
MOLECULAR CANCER THERAPEUTICS (2022)
A review on the role of cyclin dependent kinases in cancers
Soudeh Ghafouri-Fard et al.
CANCER CELL INTERNATIONAL (2022)
Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
Anna Borgenvik et al.
CANCER RESEARCH (2022)
Analysis of Dormancy-Associated Transcriptional Networks Reveals a Shared Quiescence Signature in Lung and Colorectal Cancer
Adriano Cuccu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Sorting-free metabolic profiling uncovers the vulnerability of fatty acid β-oxidation in in vitro quiescence models
Karin Ortmayr et al.
MOLECULAR SYSTEMS BIOLOGY (2022)
Integrins in Health and Disease
Susanna C. Fagerholm
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Novel Approaches in Non-Melanoma Skin Cancers-A Focus on Hedgehog Pathway in Basal Cell Carcinoma (BCC)
Paulina Chmiel et al.
CELLS (2022)
When dormancy fuels tumour relapse
Karla Santos-de-Frutos et al.
COMMUNICATIONS BIOLOGY (2021)
Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy
Sumaiyah K. Rehman et al.
CELL (2021)
Resistance of Hypoxic Cells to Ionizing Radiation Is Mediated in Part via Hypoxia-Induced Quiescence
Apostolos Menegakis et al.
CELLS (2021)
Kinome-Wide siRNA Screening Identifies DYRK1B as a Potential Therapeutic Target for Triple-Negative Breast Cancer Cells
Chia-Che Chang et al.
CANCERS (2021)
Innovative Approaches in the Battle Against Cancer Recurrence: Novel Strategies to Combat Dormant Disseminated Tumor Cells
Scott Sauer et al.
FRONTIERS IN ONCOLOGY (2021)
Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview
Mattias F. Lindberg et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Role of Small Molecule Targeted Compounds in Cancer: Progress, Opportunities, and Challenges
Guoqiang Sun et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Visualization of endogenous p27 and Ki67 reveals the importance of a c-Myc-driven metabolic switch in promoting survival of quiescent cancer cells
Ting La et al.
THERANOSTICS (2021)
CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic Adenocarcinoma
Beatriz Salvador-Barbero et al.
CANCER CELL (2020)
CPF impedes cell cycle re-entry of quiescent lung cancer cells through transcriptional suppression of FACT and c-MYC
Ling Bi et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer
Federica Francescangeli et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy
Francisco Triana-Martinez et al.
CELLS (2020)
Discoidin Domain Receptors, DDR1b and DDR2, Promote Tumour Growth within Collagen but DDR1b Suppresses Experimental Lung Metastasis in HT1080 Xenografts
Benjamin Wasinski et al.
SCIENTIFIC REPORTS (2020)
The force awakens: metastatic dormant cancer cells
So-Yeon Park et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer
Lei Ding et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The DYRK Family of Kinases in Cancer: Molecular Functions and Therapeutic Opportunities
Jacopo Boni et al.
CANCERS (2020)
Descriptive Proteome Analysis to Investigate Context-Dependent Treatment Responses to OXPHOS Inhibition in Colon Carcinoma Cells Grown as Monolayer and Multicellular Tumor Spheroids
Julia Steinmetz et al.
ACS OMEGA (2020)
Role of YES1 amplification in EGFR mutation-positive non-small cell lung cancer: Primary resistance to afatinib in a patient
Junyan Tao et al.
THORACIC CANCER (2020)
Cancer metabolism and mitochondria: Finding novel mechanisms to fight tumours
Sonia Missiroli et al.
EBIOMEDICINE (2020)
The dormant cancer cell life cycle
Tri Giang Phan et al.
NATURE REVIEWS CANCER (2020)
Strategies to improve tumor penetration of nanomedicines through nanoparticle design
Ya-Ru Zhang et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2019)
Biological Rationale for Targeting MEK/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation
Francesco Marampon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Research progress on therapeutic targeting of quiescent cancer cells
Jinhua Zhang et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
YES1 Is a Targetable Oncogene in Cancers Harboring YES1 Gene Amplification
Natsuki Hamanaka et al.
CANCER RESEARCH (2019)
Tumor Dormancy and Interplay with Hypoxic Tumor Microenvironment
Elena Butturini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Putting the brakes on the cell cycle: mechanisms of cellular growth arrest
Lindsey R. Pack et al.
CURRENT OPINION IN CELL BIOLOGY (2019)
Efficacy and safety of Vismodegib treatment in patients with advanced basal cell carcinoma and multiple comorbidities
Giulia Spallone et al.
DERMATOLOGIC THERAPY (2019)
Multiple Targets of the Canonical WNT/β-Catenin Signaling in Cancers
Yves Lecarpentier et al.
FRONTIERS IN ONCOLOGY (2019)
A wake-up call to quiescent cancer cells - potential use of DYRK1B inhibitors in cancer therapy
Walter Becker
FEBS JOURNAL (2018)
An inhibitor of oxidative phosphorylation exploits cancer vulnerability
Jennifer R. Molina et al.
NATURE MEDICINE (2018)
YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics
Pang-Dian Fan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence
Isabel Puig et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Genetic regulation of mitotic competence in G0 quiescent cells
Kenichi Sajiki et al.
SCIENCE ADVANCES (2018)
A p53-Responsive miRNA Network Promotes Cancer Cell Quiescence
Ting La et al.
CANCER RESEARCH (2018)
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
Christopher S. Garris et al.
IMMUNITY (2018)
A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy
Adriana Sanchez-Danes et al.
NATURE (2018)
Tumour-targeting bacteria engineered to fight cancer
Shibin Zhou et al.
NATURE REVIEWS CANCER (2018)
Cell-cycle-dependent drug-resistant quiescent cancer cells induce tumor angiogenesis after chemotherapy as visualized by real-time FUCCI imaging
Shuya Yano et al.
CELL CYCLE (2017)
Dyrk1B overexpression is associated with breast cancer growth and a poor prognosis
Yingying Chen et al.
HUMAN PATHOLOGY (2017)
Characterization and functional analysis of a slow-cycling subpopulation in colorectal cancer enriched by cell cycle inducer combined chemotherapy
Feng-Hua Wu et al.
ONCOTARGET (2017)
Genomic Aberrations that Activate D-type Cyclins Are Associated with Enhanced Sensitivity to the CDK4 and CDK6 Inhibitor Abemaciclib
Xueqian Gong et al.
CANCER CELL (2017)
AKT1low quiescent cancer cells persist after neoadjuvant chemotherapy in triple negative breast cancer
Sheheryar Kabraji et al.
BREAST CANCER RESEARCH (2017)
Cell-Cycle Regulation Accounts for Variability in Ki-67 Expression Levels
Michal Sobecki et al.
CANCER RESEARCH (2017)
Cell cycle proteins as promising targets in cancer therapy
Tobias Otto et al.
NATURE REVIEWS CANCER (2017)
Bone marrow micrometastases in early breast cancer-30-year outcome
J. Mansi et al.
BRITISH JOURNAL OF CANCER (2016)
Rebound Effects Caused by Withdrawal of MET Kinase Inhibitor Are Quenched by a MET Therapeutic Antibody
Emanuela Pupo et al.
CANCER RESEARCH (2016)
Inflammation Triggers Zeb1-Dependent Escape from Tumor Latency
Jasmine M. De Cock et al.
CANCER RESEARCH (2016)
Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT
Srinivas Malladi et al.
CELL (2016)
Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells
Kyle K. Payne et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Jean Y. Tang et al.
LANCET ONCOLOGY (2016)
The cell fate: senescence or quiescence
Menderes Yusuf Terzi et al.
MOLECULAR BIOLOGY REPORTS (2016)
Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation
Z. Xi et al.
CELL DEATH & DISEASE (2016)
Regulation of cellular quiescence by YAP/TAZ and Cyclin E1 in colon cancer cells: Implication in chemoresistance and cancer relapse
Matthieu Corvaisier et al.
ONCOTARGET (2016)
M2-polarized macrophages contribute to neovasculogenesis, leading to relapse of oral cancer following radiation
Makiko Okubo et al.
SCIENTIFIC REPORTS (2016)
Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids
Wojciech Senkowski et al.
CELL CHEMICAL BIOLOGY (2016)
Myc and cell cycle control
Gabriel Bretones et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
Russell Hughes et al.
CANCER RESEARCH (2015)
Discovery and Optimization of a Novel Series of Dyrk1B Kinase Inhibitors To Explore a MEK Resistance Hypothesis
Jason G. Kettle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
A Mechanism for Asymmetric Cell Division Resulting in Proliferative Asynchronicity
Ipsita Dey-Guha et al.
MOLECULAR CANCER RESEARCH (2015)
Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer
Wojciech Senkowski et al.
MOLECULAR CANCER THERAPEUTICS (2015)
NR2F1 controls tumour cell dormancy via SOX9-and RAR beta-driven quiescence programmes
Maria Soledad Sosa et al.
NATURE COMMUNICATIONS (2015)
Comprehensive Two- and Three-Dimensional RNAi Screening Identifies PI3K Inhibition as a Complement to MEK Inhibitor AS703026 for Combination Treatment of Triple-Negative Breast Cancer
Jangsoon Lee et al.
JOURNAL OF CANCER (2015)
A novel DYRK1B inhibitor AZ191 demonstrates that DYRK1B acts independently of GSK3β to phosphorylate cyclin D1 at Thr286, not Thr288
Anne L. Ashford et al.
BIOCHEMICAL JOURNAL (2014)
Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy
Shuya Yano et al.
CELL CYCLE (2014)
Spatial-temporal FUCCI imaging of each cell in a tumor demonstrates locational dependence of cell cycle dynamics and chemoresponsiveness
Shuya Yano et al.
CELL CYCLE (2014)
Colon Cancer Cells Escape 5FU Chemotherapy-Induced Cell Death by Entering Stemness and Quiescence Associated with the c-Yes/YAP Axis
Yasmine Touil et al.
CLINICAL CANCER RESEARCH (2014)
Combined SFK/MEK inhibition prevents metastatic outgrowth of dormant tumor cells
Lara H. El Touny et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Design and Synthesis of a Library of Lead-Like 2,4-Bisheterocyclic Substituted Thiophenes as Selective Dyrk/Clk Inhibitors
Christian Schmitt et al.
PLOS ONE (2014)
Forward genetic screens in mice uncover mediators and suppressors of metastatic reactivation
Hua Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments
Xiaonan Zhang et al.
NATURE COMMUNICATIONS (2014)
Lapatinib induces p27Kip1-dependent G1 arrest through both transcriptional and post-translational mechanisms
Lin Tang et al.
CELL CYCLE (2013)
Antitumor effects of novel compound, guttiferone K, on colon cancer by p21Waf1/Cip1-mediated G0/G1 cell cycle arrest and apoptosis
Winnie Lai Ting Kan et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling
Paloma Bragado et al.
NATURE CELL BIOLOGY (2013)
Role of PI3K-AKT-mTOR and Wnt signaling pathways in transition of G1-S phase of cell cycle in cancer cells
Lakshmipathi Vadlakondalf et al.
FRONTIERS IN ONCOLOGY (2013)
Transcriptional changes induced by the tumor dormancy-associated microRNA-190
Nava Almog et al.
TRANSCRIPTION-AUSTIN (2013)
The DREAM complex: master coordinator of cell cycle-dependent gene expression
Subhashini Sadasivam et al.
NATURE REVIEWS CANCER (2013)
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen et al.
NATURE (2012)
ERK1/2 and p38α/β Signaling in Tumor Cell Quiescence: Opportunities to Control Dormant Residual Disease
Maria Soledad Sosa et al.
CLINICAL CANCER RESEARCH (2011)
p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype
Adam Freund et al.
EMBO JOURNAL (2011)
DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly
Larisa Litovchick et al.
GENES & DEVELOPMENT (2011)
Transient arrest in a quiescent state allows ovarian cancer cells to survive suboptimal growth conditions and is mediated by both Mirk/dyrk1b and p130/RB2
Jing Hu et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Inactivation of Mirk/Dyrk1b Kinase Targets Quiescent Pancreatic Cancer Cells
Daina Z. Ewton et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Asymmetric cancer cell division regulated by AKT
Ipsita Dey-Guha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
Rb inactivation in cell cycle and cancer The puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase
Sabine Paternot et al.
CELL CYCLE (2010)
Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium
H. Kimura et al.
CELL PROLIFERATION (2010)
Mirk/Dyrk1B Maintains the Viability of Quiescent Pancreatic Cancer Cells by Reducing Levels of Reactive Oxygen Species
Xiaobing Deng et al.
CANCER RESEARCH (2009)
Mirk Regulates the Exit of Colon Cancer Cells from Quiescence
Kideok Jin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
IFNα activates dormant haematopoietic stem cells in vivo
Marieke A. G. Essers et al.
NATURE (2009)
Interleukin-6 predicts recurrence and survival among head and neck cancer patients
Sonia A. Duffy et al.
CANCER (2008)
Cell Cycle Genes Are the Evolutionarily Conserved Targets of the E2F4 Transcription Factor
Caitlin M. Conboy et al.
PLOS ONE (2007)
A new description of cellular quiescence
HA Coller et al.
PLOS BIOLOGY (2006)
A pooled analysis of bone marrow micrometastasis in breast cancer
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Mirk/Dyrk1B mediates survival during the differentiation of C2C12 myoblasts
SE Mercer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The cyclin-dependent kinase inhibitor p27Kip1 is stabilized in G0 by Mirk/dyrk1B kinase
XB Deng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Inhibition of phosphorylation of BAD and Raf-1 by Akt sensitizes human ovarian cancer cells to paclitaxel
S Mabuchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Multifaceted regulation of cell cycle progression by estrogen: Regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function
JS Foster et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
分享论文
